Reticular

Reticular · Embryo Report · Core

Sample report
Physician summary (print)

Nadia and Theo's embryo report

5 embryos reviewed · chromosome results and viability genes

Every embryo, at a glance.

  • No known risks
  • Moderate risk
  • Higher risk
Chromosome result and viability-gene review for each embryo
ResultEmbryo 4E-4AA-7F3CEmbryo 2E-5AB-2A91Embryo 7E-5BA-4C26Embryo 6E-4BA-8D42Embryo 5E-3BB-1C57
Chromosomes
Euploid
Euploid
Euploid
Low-level mosaic
Aneuploid
Viability genes
No known risks

No finding

Moderate risk

F5c.1601G>A

Higher risk

TUBB8c.686T>C

Higher risk

TUBB8c.686T>C

Higher risk

Not assessed

Embryo grade4AADay 5 blastocyst5ABDay 5 blastocyst5BADay 5 blastocyst4BADay 5 blastocyst3BBDay 6 blastocyst
SexFemale46,XXMale46,XYMale46,XYFemale46,XXMale46,XY

Where the chromosome result already explains the risk, viability genes are not separately assessed. Sex is reported, never ranked.

Clinical summary

Embryo 4 is the best fit to transfer first: euploid, with no reportable pregnancy-loss gene finding.

Three of these five embryos are chromosomally normal, and only Embryo 4 is also clear on the viability genes. The order below follows the chromosome result first, then the viability-gene review, then grade.

A suggested order, not a transfer decision. A finding does not mean an embryo will fail, and a clear result does not guarantee a transfer will succeed — grade, your history, and your clinic's judgment all belong in the call. Nothing either of you did caused these findings.

Inherited variants

What you both carry.

Both partners were sequenced across the panel. These are the reportable findings, with the embryos each was seen in — the per-embryo review below says what each one means for that embryo.

  • TUBB8

    Published reproductive evidence

    Higher risk

    A published TUBB8 variant was identified in a gene with strong evidence for oocyte maturation problems and early embryo arrest, so the finding may be relevant to reproductive counseling. Maternal-effect / oocyte biology.

    • Nadia

      Egg source

      c.686T>C (p.Val229Ala)

      Known to be harmful (pathogenic)

      Carrier
    • Theo

      Sperm source

      Not detected

      No reportable variant in this gene

      Not detected

    Reported in: Embryo 7 and Embryo 6.

  • F5

    Known variant, limited pregnancy-loss evidence

    Moderate risk

    A known F5 variant was identified, but the published pregnancy-loss evidence is limited and context-dependent. Weigh it against your full fertility history — your Reticular genetic counselor can help you put it in perspective. Autosomal dominant thrombophilia variant.

    • Nadia

      Egg source

      Not detected

      No reportable variant in this gene

      Not detected
    • Theo

      Sperm source

      c.1601G>A (Factor V Leiden)

      Known to be harmful (pathogenic)

      Carrier

    Reported in: Embryo 2.

Results by embryo

Embryo prioritization based on results.

  1. Best fit · Suggested order

    Embryo 4

    E-4AA-7F3C · Day 5 blastocyst

    EuploidNo known risksGrade 4AAFemale

    Transfer Embryo 4 first — the only embryo in this cohort that is euploid with no reportable pregnancy-loss gene finding.

    No high-priority inherited findings were identified in the curated set of genes associated with pregnancy loss and embryonic viability.

  2. Fit 2 · Suggested order

    Embryo 2

    E-5AB-2A91 · Day 5 blastocyst

    EuploidModerate riskGrade 5ABMale

    Embryo 2 is next: also euploid, and its F5 finding rests on evidence too limited and context-dependent to move it down the list.

    • F5

      F5 c.1601G>A (Factor V Leiden)

      Moderate risk
      Inherited

      Heterozygous

  3. Fit 3 · Suggested order

    Embryo 7

    E-5BA-4C26 · Day 5 blastocyst

    EuploidHigher riskGrade 5BAMale

    Embryo 7 sits behind the other two euploid embryos because of a published TUBB8 variant tied to early embryo arrest — the kind of finding a chromosome count cannot see.

    • TUBB8

      TUBB8 c.686T>C (p.Val229Ala)

      Higher risk
      Acts through the egg

      Acts through the egg, not the embryo's own copy

  4. Fit 4 · Suggested order

    Embryo 6

    E-4BA-8D42 · Day 5 blastocyst

    Low-level mosaicHigher riskGrade 4BAFemale

    Consider Embryo 6 only after all three euploid embryos: a low-level mosaic result and the same higher-risk TUBB8 variant add uncertainty on two fronts.

    • TUBB8

      TUBB8 c.686T>C (p.Val229Ala)

      Higher risk
      Acts through the egg

      Acts through the egg, not the embryo's own copy

  5. Lower fit · Suggested order

    Embryo 5

    E-3BB-1C57 · Day 6 blastocyst

    AneuploidHigher riskGrade 3BBMale

    Embryo 5 is the lowest priority here, because whole-chromosome aneuploid embryos rarely lead to a healthy live birth.

    PGT-A detected aneuploidy in this embryo. That chromosome result is the primary viability concern in this report.

What Core screened

Genes reviewed in every embryo.

Grouped by what each gene does in embryo viability and pregnancy loss, with every group's gene list shown in full and counted exactly. Both partners are screened across the wider 750+ gene panel; the groups below are the ones reviewed in each of your embryos.

Genes that help the egg mature and divide

18 genes · full list

TUBB8 · 2 embryos

These genes help an egg finish maturing and line up its chromosomes to divide. A fault — TUBB8 is the classic example — can leave eggs unable to mature or embryos stalling in the first few days, before a pregnancy can take hold.

TUBB8PATL2TRIP13TACC3CDC20KIF11TUBA4AKIF18AHAUS6LHX8TBPL2ZFP36L2

Gene list sources: ESHRE FeRGI Database · Curated published literature

Genes for fertilization

10 genes · full list

No findings

These genes handle fertilization — the egg's outer coat (the zona pellucida) and the signal sperm use to switch the egg on. A fault can cause fertilization to fail even when the egg and sperm look normal.

ZP1WEE2PLCZ1ZP2ZP3ZP4ASTLACTL7AACTL9IZUMO1R

Gene list sources: ESHRE FeRGI Database · Curated published literature

Genes that run the embryo's first days

12 genes · full list

No findings

The egg stores a “starter kit” of genes that run the embryo's first divisions. A fault makes embryos stop growing at the same early stage, cycle after cycle — a signal that points to egg biology, not anything either of you did.

PADI6TLE6NLRP5NLRP2BTG4CHEK1OOEPKPNA7MOSFBXO43MEI4PANX1

Gene list sources: ESHRE FeRGI Database · Curated published literature

Genes tied to molar pregnancy

5 genes · full list

No findings

These genes set the maternal “imprint” (a chemical tag on the egg's genes) that an embryo needs. A fault can cause molar pregnancies — abnormal tissue growth instead of a healthy pregnancy — and repeat losses that trace to egg biology, with any partner.

NLRP7KHDC3LMEI1TOP6BLREC114

Gene list source: ESHRE FeRGI Database

Genes a pregnancy needs to keep growing

182 genes · full list

No findings

Genes an embryo needs to keep developing through pregnancy, from the published Human Intolerome. Where both partners carry a fault in the same gene, Core checks which of your embryos inherited both copies — a cause of loss that chromosome testing cannot see.

AAASABCB4ABCC6ACO2ACTA1ACTG2ADAMTS2ADGRG6ADSLAGKAGTAGTR1

Gene list source: RPLdb Human Intolerome

Blood-clotting & pregnancy-support genes

12 genes · full list

F5 · Embryo 2

Clotting and pregnancy-support genes — like Factor V Leiden (F5) — that can raise the risk of later loss. Their link to early loss is weaker and depends on the whole clinical picture.

F5F2SERPINC1PROCPROS1ANXA5NOS3SERPINE1F13A1THBDFGAFLT1

Gene list sources: ESHRE FeRGI Database · Curated published literature

Questions about a report like this?

Genetic counseling is included with every Core report, and Christina is available to clinical teams for case review.

Book a conversation (opens in a new tab)

Reticular embryo report · Core · pipeline 2026.05 · GRCh38 · Nadia and Theo IVF cohort

For demonstration and reference only — not medical advice. Results are informational and do not diagnose a condition, explain every pregnancy loss, recommend treatment, or guarantee an outcome. Findings should be confirmed and interpreted with a qualified clinician or genetic counselor.